Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A <scp>discrete choice experiment</scp>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment

Published:2022-07-26 Issue:3 Volume:12 Page:3376-3386
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Amaador Karima¹²^ORCID,Nieuwkerk Pythia T.³,Minnema Monique C.⁴^ORCID,Kersten Marie José¹²,Vos Josephine M. I.¹²^ORCID

Affiliation:

1. Amsterdam UMC, University of Amsterdam, Department of Hematology Cancer Center Amsterdam Amsterdam The Netherlands

2. Lymphoma and Myeloma Center Amsterdam (LYMMCARE) Amsterdam The Netherlands

3. Department of Medical Psychology Academic Medical Center Amsterdam The Netherlands

4. Department of Hematology, University Medical Center Utrecht University Utrecht Utrecht The Netherlands

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5080

Reference35 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

3. Competing risk survival analysis in patients with symptomatic Waldenstrom macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

4. Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy

5. Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia;Hematology/Oncology Clinics of North America;2023-08

2. Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia;Hematological Oncology;2023-07-17

3. Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials;Seminars in Hematology;2023-03

4. First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline;Hemato;2022-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3